We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$283B
AUM Growth
+$24.6B
Cap. Flow
+$7.48B
Cap. Flow %
2.64%
Top 10 Hldgs %
23.42%
Holding
10,541
New
1,808
Increased
3,387
Reduced
3,810
Closed
1,384

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$528M
2
BA icon
Boeing
BA
+$375M
3
GE icon
GE Aerospace
GE
+$346M
4
INTC icon
Intel
INTC
+$340M
5
UNP icon
Union Pacific
UNP
+$281M

Sector Composition

Rank Sector Weight
1 Technology 2.64%
2 Consumer Discretionary 0.99%
3 Communication Services 0.98%
4 Healthcare 0.9%
5 Industrials 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TARA icon
8951
Protara Therapeutics
TARA
$233M
$37K ﹤0.01%
+493
New +$39.5K
IRD
8952
Opus Genetics
IRD
$326M
$37K ﹤0.01%
+380
New +$38.6K
TLGT
8953
PUT
DELISTED
Teligent, Inc
TLGT
$37K ﹤0.01%
+1,020
New +$48.8K
NVLN
8954
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$37K ﹤0.01%
+12,007
New +$57.7K
BORN
8955
DELISTED
China New Borun Corporation
BORN
$37K ﹤0.01%
29,247
+1,814
+7% +$2.35K
IPCI
8956
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$37K ﹤0.01%
4,614
+758
+20% +$6.89K
CTIC
8957
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$37K ﹤0.01%
+13,940
New +$40.9K
OPCH icon
8958
Option Care Health
OPCH
$3.59B
$36K ﹤0.01%
+3,108
New +$31.4K
SB icon
8959
CALL
Safe Bulkers
SB
$854M
$36K ﹤0.01%
11,300
-3,800
-25% -$12.2K
UTI icon
8960
Universal Technical Institute
UTI
$1.22B
$36K ﹤0.01%
+15,088
New +$47.5K
TLGT
8961
CALL
DELISTED
Teligent, Inc
TLGT
$36K ﹤0.01%
1,000
-1,240
-55% -$59.3K
CXRX
8962
PUT
DELISTED
Concordia International Corp. Common Stock
CXRX
$36K ﹤0.01%
55,000
-800
-1% -$551
DRRX
8963
CALL
DELISTED
DURECT Corp
DRRX
$35K ﹤0.01%
3,830
-1,100
-22% -$13.1K
ALIM
8964
DELISTED
Alimera Sciences
ALIM
$35K ﹤0.01%
+1,740
New +$34K
FRTX
8965
CALL
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$35K ﹤0.01%
60
-13
-18% -$8.57K
SYNC
8966
PUT
DELISTED
Synacor, Inc.
SYNC
$35K ﹤0.01%
15,400
+2,500
+19% +$6.21K
I
8967
CALL
DELISTED
INTELSAT S. A.
I
$35K ﹤0.01%
+10,200
New +$45.5K
INTX
8968
DELISTED
Intersections, Inc.
INTX
$35K ﹤0.01%
15,267
-86,147
-85% -$219K
CIG icon
8969
CALL
CEMIG Preferred Shares
CIG
$5.72B
$34K ﹤0.01%
32,566
-105,741
-76% -$120K
RGLS
8970
DELISTED
Regulus Therapeutics
RGLS
$34K ﹤0.01%
+272
New +$34.4K
CCLD icon
8971
CareCloud
CCLD
$109M
$33K ﹤0.01%
+12,514
New +$35.7K
CYTO
8972
DELISTED
Altamira Therapeutics Ltd
CYTO
$33K ﹤0.01%
+1
New +$54.4K
WMGIZ
8973
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
$33K ﹤0.01%
21,731
+6,921
+47% +$10.7K
RMGN
8974
DELISTED
RMG Networks Holding Corporation
RMGN
$33K ﹤0.01%
+39,891
New +$52.3K
LUNA
8975
DELISTED
Luna Innovations Incorporated
LUNA
$33K ﹤0.01%
+13,625
New +$26.7K

Similar funds

Jeff Yass's Q4 2017 Portfolio in Review

As of Q4 2017, Jeff Yass held 10,541 positions worth $283B, up 9.5% from $259B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jeff Yass's Q4 2017 filing shows 1,808 new, 3,387 increased, 3,810 reduced and 1,384 closed positions. Its largest new stake was Union Pacific: 2,326,570 shares worth $312M. The largest sale was Amazon, an estimated $695M.

By sector, the portfolio is most concentrated in Technology at 2.6% of assets, up from 2.4% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Jeff Yass's largest Q4 2017 buy was Union Pacific: 2,326,570 shares worth $312M.
  • Jeff Yass added most to Apple in Q4 2017, an estimated $528M increase.
  • Jeff Yass's biggest Q4 2017 reduction was Amazon, cutting an estimated $695M.
  • Jeff Yass fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, selling an estimated $639M.
  • Jeff Yass's ten largest holdings make up 23% of its $283B portfolio in Q4 2017.
  • Jeff Yass opened 1,808 new positions and closed 1,384 in Q4 2017.
  • Jeff Yass's portfolio value rose 9.5% quarter-over-quarter to $283B.

Based on Susquehanna International Group's 13F filing for Q4 2017, filed 14 Feb 2018.